ID: ALA4800463

Max Phase: Preclinical

Molecular Formula: C15H21NO2

Molecular Weight: 247.34

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  CC1CC(OC(=O)c2ccccc2)CC(C)(C)N1

Standard InChI:  InChI=1S/C15H21NO2/c1-11-9-13(10-15(2,3)16-11)18-14(17)12-7-5-4-6-8-12/h4-8,11,13,16H,9-10H2,1-3H3

Standard InChI Key:  ZYHGIAPHLSTGMX-UHFFFAOYSA-N

Associated Targets(non-human)

SARS-CoV-2 38078 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: YesOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 247.34Molecular Weight (Monoisotopic): 247.1572AlogP: 2.76#Rotatable Bonds: 2
Polar Surface Area: 38.33Molecular Species: BASEHBA: 3HBD: 1
#RO5 Violations: 0HBA (Lipinski): 3HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 10.29CX LogP: 2.73CX LogD: 0.00
Aromatic Rings: 1Heavy Atoms: 18QED Weighted: 0.82Np Likeness Score: 0.60

References

1. Ellen Van Damme.  (2021)  Screening of ~5500 FDA-approved drugs and clinical candidates for anti-SARS-CoV-2 activity,  [10.6019/CHEMBL4651402]

Source